2008 sumo cannabis scandal

EQS-News: Cantourage Group SE records significant revenue growth in the first nine months of 2023 and confirms full-year forecast

Retrieved on: 
Mittwoch, Dezember 13, 2023

In the third quarter of 2023 revenue increased to EUR 6.1 million* (Q3 2022: EUR 3.4 million*).

Key Points: 
  • In the third quarter of 2023 revenue increased to EUR 6.1 million* (Q3 2022: EUR 3.4 million*).
  • Based on the expectations for the current quarter, Cantourage continues to expect to achieve its forecast for the full year 2023.
  • Bernd Fischer, CFO of Cantourage, states: "Our business development was successful in the first nine months of 2023.
  • As a result of this and cost-saving measures, we expect to achieve our forecast business development for 2023 as planned."

EQS-News: Cantourage Group SE welcomes SUMO Cannabis: New partner focuses on particularly resource-saving aeroponic cultivation technology

Retrieved on: 
Donnerstag, August 10, 2023

Cantourage Group SE welcomes SUMO Cannabis: New partner focuses on particularly resource-saving aeroponic cultivation technology

Key Points: 
  • Cantourage Group SE welcomes SUMO Cannabis: New partner focuses on particularly resource-saving aeroponic cultivation technology
    The issuer is solely responsible for the content of this announcement.
  • Cantourage Group SE welcomes SUMO Cannabis: New partner focuses on particularly resource-saving aeroponic cultivation technology
    Berlin, August 10, 2023 – Cantourage Group SE (hereinafter “Cantourage,” ISIN: DE000A3DSV01), a leading European company for the production and distribution of medicinal cannabis, has announced that SUMO Cannabis, another major producer, has been acquired as a partner to supply to the European market for medicinal cannabis.
  • SUMO Cannabis maintains its cultivation operation in Trois-Rivières, in the heart of the province of Québec, Canada.
  • “We are delighted to have gained another cultivation partner in SUMO Cannabis, who shares our passion for cannabis products.